Your search for ‘Reed Smith’ returned 9,636 results

The Settlement Conference Facilitation program is a pilot alternate dispute resolution process designed to bring the appellant and CMS together.

President Obama recently signed into law S. 330, the HIV Organ Policy Equity Act, which eliminates the restriction on acquiring HIV-positive organs in order to permit research on transplants involving HIV-positive individuals.

On September 12, 2013, the House of Representatives approved H.R. 2775, the "No Subsidies Without Verification Act," on a vote of 235 to 191.

The House of Representatives has voted 307 – 111 to approve HR 849, Protecting Seniors' Access to Medicare Act, to repeal the Independent Payment Advisory Board (IPAB).

On September 21, 2016, the House of Representatives approved HR 5659, the Expanding Seniors Receiving Dialysis Choice Act of 2016, which would allow Medicare beneficiaries with end stage renal disease (ESRD) to enroll in Medicare Advantage plans beginning in 2020

The House of Representatives has voted 283 – 132 to approve legislation (HR 184) that would permanently repeal the Affordable Care Act's 2.3% excise tax on the sale of certain medical devices.

The House Energy and Commerce Health Subcommittee has scheduled a November 17, 2015 hearing on the regulation of diagnostic tests and laboratory operations.

On September 9, 2015, the House Energy and Commerce Committee is holding a hearing on H.R. 1624, Protecting Affordable Coverage for Employees Act of 2015.

On February 10, the House Energy and Commerce Subcommittee on Health held a hearing entitled "Examining Drug Shortages and Recent Efforts to Address Them."

The House Energy and Commerce Subcommittee on Health has approved two bills that would modify Medicaid eligibility rules to consider additional sources of income.

The House of Representatives is scheduled to take up legislation on November 15, 2013 that responds to growing attention to policy cancellations in the individual health insurance market linked to more stringent coverage requirements going into effect in 2014 under the ACA.

On September 29, 2015, the House Ways and Means Committee approved budget "reconciliation" legislation that calls for repeal of five provisions of the Affordable Care Act (ACA).

The Health Resources and Services Administration (HRSA) has adopted its proposal to delay the effective date of its final rule revising the calculation of the 340B "ceiling price" that may be charged to covered entities and related civil money penalties.

The Trump Administration is proposing to once again push back the effective date of a January 2017 final rule making changes to the calculation of the 340B "ceiling price" that may be charged to covered entities and related civil money penalties.

On February 12, 2014, the Internal Revenue Service (IRS) published final regulations modifying the timeline under which certain employers will be required to make "shared responsibility" payments if they do not provide qualified health insurance for their full-time employees and dependents pursuant to the Affordable Care Act (ACA).

The Health Resources and Services Administration (HRSA) has announced that it will implement its January 5, 2017 340B drug pricing program rule on January 1, 2019.

CMS has posted the July 2013 Medicare Part B average sales price files.

As mentioned on our Health Industry Washington Watch blog, pharmaceutical and medical device manufacturers and group purchasing organizations (GPO) are currently in the process of submitting detailed 2013 payment and investment interest data to the Centers for Medicare & Medicaid Services.